Nobuyuki Koga

Specially Appointed Associate Professor

Tokushima University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nobuyuki Koga is a Specially Appointed Associate Professor at Tokushima University in Japan. His research areas include migraine management, quality of life assessments in headache patients, and treatment efficacy of various migraine therapies, particularly focusing on the effects of fremanezumab and brexpiprazole. His recent publications address the psychological and health outcomes for patients with chronic migraines, including factors influencing the decision to seek medical treatment.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Masaki Kato

Associate Professor

Kansai Medical University

JAPAN

View details

Norihiro Suzuki

Chief Excutive Director

Kure Kyosai Hospital

JAPAN

View details

Hiromi Sano

Otsuka Pharmaceutical

JAPAN

View details

YUKI ISOGAI

Cardiology, Medical Science / Section chief

Otsuka Pharmaceutical

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nobuyuki Koga

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double‐blind (BLESS) study

Quality of life and work productivity and activity impairment among online survey respondents with migraine across a range of headache frequency

Characteristics of patients who seek medical attention for headache and those who do not: cross-sectional survey and linked medical claims data analysis in Japan

Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trials

A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home

Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan

Therapeutic result and safety of Fremanezumab in patients of chronic migraine

A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan.

Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Collaborators (4)

Masaki Kato

Norihiro Suzuki

Hiromi Sano

YUKI ISOGAI

Make your next move.